Prostate Cancer Breakthrough-DNDN
Airtime: Thurs. Apr. 29 2010 | 7:45 PM ET
CNBC’s Bertha Coombs has the details on a major breakthrough on a therapeutic cancer vaccine.
Similar Posts
Citi Earnings Reaction
Chris Whalen, managing director of Institutional risk Analytics, shares his reaction to Citi’s quarterly results.
European Retail Participation in ETFs Only at 10%
“In the European marketplace, not withstanding that we’re ten years into this, we’re still in very, very early days,” Ted Hood, CEO of Source, creator of ETF products, said of ETFs. “In the US market, we’re seeing 50% retail participation in ETFs.”
Turning Air Into a Glass of Water
Richard Koh, executive chairman of Pan Asian Water Solutions, demonstrates a device which can transform air into water within seconds. He explains the various applications of this piece of technology to CNBC’s Sri Jegarajah.
The Buffett Express, Pt. 1
CNBC’s Becky Quick goes one-on-one with Berkshire Hathaway CEO Warren Buffett to discuss the Goldman Sachs fraud charges, financial regulation and more.
Australia to Elect New PM Next Month
Colin Whitehead, analyst, Fat Prophets shares his views on Australia’s prime ministerial candidates, Tony Abbott and Julia Gillard, and their challenges ahead, with CNBC’s Martin Soong, Karen Tso and Sri Jegarajah.
Goldman Sachs Earnings Analysis Q1 2010
Parsing Goldman’s quarterly results with Ed Najarian, of ISI, and Brad Hintz, of Bernstein Research.
